Enzocort 6 Tablet contains Deflazacort 6 mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus, polymyositis, and dermatomyositis. Deflazacort exerts its therapeutic effects by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing tissue inflammation and immune-mediated damage. Enzocort 6 is also utilized in the treatment of allergic disorders, chronic obstructive pulmonary disease exacerbations, and certain hematologic conditions. The dosage and duration of therapy should be individualized based on the severity of the disease and patient response, with gradual tapering recommended to minimize the risk of adrenal insufficiency. Common adverse effects may include weight gain, hypertension, hyperglycemia, mood alterations, and increased susceptibility to infections. Caution is advised in patients with diabetes, hypertension, osteoporosis, and peptic ulcer disease. Regular monitoring of blood pressure, blood glucose, and electrolyte levels is essential during prolonged therapy. Enzocort 6 should be used under strict medical supervision to ensure optimal therapeutic outcomes and minimize potential side effects associated with corticosteroid use.